Report Content
Chapter 1 Methodology
1.1 Market definition
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Contract research organization industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Service type trends
2.1.3 Therapeutic area trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Contract Research Organization Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing R&D expenditure worldwide
3.3.1.2 Growing number of clinical trials in emerging countries
3.3.1.3 Growing outsourcing of R&D activities
3.3.1.4 Rising technological advancements
3.3.2 Industry pitfalls & challenges
3.3.2.1 Intellectual property rights issues
3.3.2.2 Stringent regulatory policies
3.4 Growth potential analysis
3.4.1 By service type
3.4.2 By therapeutic area
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Clinical trial volume analysis
3.6.1 Clinical trial volume analysis, by region, 2018 - 2021
3.6.2 Clinical trial volume analysis, by indication, 2018 - 2021
3.6.3 Clinical trial volume analysis, by phase of development, 2018 - 2021
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.7.3 Asia Pacific
3.7.3.1 Singapore
3.7.3.2 Malaysia
3.7.3.3 Indonesia
3.7.3.4 Thailand
3.7.3.5 South Korea
3.7.3.6 Philippines
3.8 Clinical trials- Asia Pacific advantage
3.9 Industry ecosystem analysis
3.10 Drug discovery and development process
3.11 Porter’s analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Strategic dashboard, 2022
4.5 Merger & acquisition landscape
4.5.1 Merger & acquisition deals in the CRO industry, 2018 – 2022
4.5.2 Completed contract research organization merger & acquisition deals, 2018-2021
4.5.3 Influence of private equity in CRO mergers & acquisitions
4.5.3.1 PRA Health Sciences
4.5.3.2 Medpace, Inc.
4.5.3.3 PPD, Inc.
4.5.3.4 Parexel International Corporation
4.5.4 Impact of industry consolidation on the overall market
4.5.5 Analyst insights
Chapter 5 Contract Research Organization Market, By Service Type
5.1 Key service type trends
5.2 Early phase development services
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Discovery phase
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Chemistry, manufacturing & control (CMC)
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4 Preclinical services
5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4.2 Pharmacokinetic/Pharmacodynamic (PK/PD)
5.2.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4.3 Toxicology testing services
5.2.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4.4 Others
5.2.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Clinical research services
5.3.1 Phase I
5.3.1.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Phase II
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Phase III
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4 Phase IV
5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Laboratory services
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Bioanalytical testing services
5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3 Analytical testing services
5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3.2 Physical characterization
5.4.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3.3 Raw material testing
5.4.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3.4 Batch release testing
5.4.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3.5 Stability testing
5.4.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3.6 Others
5.4.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5 Regulatory consulting services
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Contract Research Organization Market, By Therapeutic Area
6.1 Key therapeutic area trends
6.2 Oncology
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Clinical pharmacology
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Cardiology
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Infectious disease
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Neurology
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 Gastroenterology & hepatology
6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.8 Ophthalmology
6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.9 Others
6.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Contract Research Organization Market, By End-use
7.1 Key end-use trends
7.2 Pharmaceutical & biopharmaceutical companies
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Medical device companies
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Academic institutes
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Contract Research Organization Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
Chapter 9 Company Profiles
9.1 Charles River Laboratories International, Inc. (MPI Research)
9.2 Clinipace Inc.
9.3 CMIC HOLDINGS Co., Ltd.
9.4 EPS International Holdings Co. Ltd. (EPS Group)
9.5 ICON plc
9.6 IQVIA (Quintiles IMS Holdings, Inc.)
9.7 Laboratory Corporation of America Holdings (Covance Inc.)
9.8 Medpace, Inc.
9.9 PAREXEL International Corporation
9.10 Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
9.11 Syneos Health
9.12 Worldwide Clinical Trials
9.13 WuXi AppTec
9.14 ORA Inc.
9.15 CTRG (Clinical Trial Resource Group)
9.16 Iris Pharma
9.17 Trial Runners
9.18 The Emmes Company, LLC
9.19 Lexitas Pharma Services, Inc.
9.20 JANIX
9.21 ProTrial Research, Inc.
9.22 TFS HealthScience
